Trial of DA-EPOCH Regimen for NHL With HLH
|2||Not yet recruiting||
R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL
Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
† Study has passed its completion date and status has not been verified in more than two years.